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Abstract
PURPOSE: To assess quality of life and climacteric symptoms in women with and without liver transplants. METHODS: This 
was a cross-sectional study of 52 women undergoing follow-up at a university hospital in southeastern Brazil from 
February 4th, 2009 to January 5th, 2011. Twenty-four of these women were 35 years old or older and had undergone 
liver transplantation at least one year before study entry. The remaining 28 women had no liver disease and were 
matched by age and menstrual patterns to the patients with transplants. The abbreviated version of the World Health 
Organization (WHOQOL-BREF) questionnaire was used to assess quality of life. Menopausal symptoms were assessed 
using the Menopause Rating Scale (MRS). Statistical analysis was carried out by Student’s t -test, Mann-Whitney test and 
analysis of variance. Correlations between MRS and the WHOQOL-BREF were established by correlation coefficients. 
RESULTS: The mean age of the women included in the study was 52.2 (±10.4) years and the mean time since 
transplantation was 6.1 (±3.3) years. Women with liver transplants had better quality of life scores in the environment 
domain (p=0.01). No difference was noted between the two groups in any domain of the MRS. For women in the 
comparison group, there was a strongly negative correlation between somatic symptoms in the MRS and the physical 
domain of the WHOQOL-BREF (p<0.01; r=-0.8). In contrast, there was only a moderate association for women with 
liver transplants (p<0.01; r=-0.5). CONCLUSIONS: Women with liver transplants had better quality of life scores in 
the domain related to environment and did not exhibit more intense climacteric symptoms than did those with no liver 
disease. Climacteric symptoms negatively influenced quality of life in liver transplant recipients, although less intensely 
than in women without a history of liver disease.
Resumo
OBJETIVO: Avaliar a qualidade de vida e os sintomas do climatério em mulheres com e sem transplante de fígado. 
MÉTODOS: Estudo de corte transversal com 52 mulheres em acompanhamento ambulatorial em um hospital universitário 
na região sudeste do Brasil no período de 04/02/09 a 05/01/11. Dessas mulheres, 24 tinham 35 anos ou mais e 
haviam sido submetidas a transplante de fígado a pelo menos um ano antes do início do estudo. As outras 28 mulheres 
não tinham doença hepática e suas idades e padrões menstruais eram similares ao das transplantadas hepáticas. Para 
avaliação da qualidade de vida foi usada a versão abreviada do questionário da Organização Mundial da Saúde 
(WHOQOL-bref). Os sintomas da menopausa foram avaliados através do Menopause Rating Scale (MRS). A análise 
estatística foi realizada através dos testes t de Student, Mann-Whitney e ANOVA. As correlações entre o MRS e o 
WHOQOL-bref foram realizadas através de coeficientes de correlação. RESULTADOS: A idade média das mulheres 
incluídas no estudo foi de 52,2 (±10,4) anos e o tempo médio desde a realização do transplante foi de 6,1 (±3,3) 
anos. As mulheres transplantadas hepáticas tiveram melhores escores de qualidade de vida no domínio relacionado 
ao meio ambiente (p=0,01). Não houve diferença entre os dois grupos em nenhum domínio do MRS. As mulheres no 
grupo de comparação tiveram uma correlação fortemente negativa entre os sintomas somáticos do MRS e o domínio 
físico do WHOQOL-bref (p<0,01; r=-0,8), diferentemente das mulheres com transplante de fígado que tiveram uma 
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Introduction
Liver transplantation aims to prolong the sur-
vival of patients with end-stage liver disease. Five- and 
ten-year survival rates are around 70 and 60%, respec-
tively1. Increasing survival has led to a greater concern 
with quality of life after transplantation2. Previous studies 
have shown that patients undergoing liver transplantation 
have alterations in quality of life, with increased fatigue, 
physical problems and a higher prevalence of depres-
sion and anxiety after transplantation than before it3–6. 
However, despite resulting in some negative changes, liver 
transplantation leads to an overall improved quality of life 
for patients and their caregivers and companions7,8. This 
improvement often becomes apparent three to five years 
after transplantation, by which time patients typically 
achieve a new level of psychosocial stability9. 
Women account for approximately one-third of 
patients undergoing liver transplantation. The major 
causes of liver failure indicating liver transplantation 
in these women are primary biliary cirrhosis and cir-
rhosis secondary to post-viral hepatitis and autoim-
mune hepatitis10. In Brazil, alcohol abuse and chronic 
hepatitis C are also important indications for liver 
transplantation11. The liver is an essential organ to sex 
hormone metabolism. It conjugates estrogens to form 
glucuronides and sulfates. About one-fifth of these 
products are excreted in bile, while most of the remain-
der is excreted in urine. Furthermore, liver converts 
the estrogens estradiol and estrone into estriol, which 
is a less potent estrogen12. Women with severe liver 
disease have alterations in liver function which may 
compromise the metabolism of sex hormones and sex 
hormone-binding globulin (SHBG), leading to clini-
cal repercussions. Studies on hypogonadism in liver 
transplant recipients have largely assessed only men. 
The few studies that have evaluated women undergo-
ing transplantation have determined that the main 
gynecologic repercussions are abnormalities in the 
menstrual cycle. Following transplantation, 80 to 90% 
of women recover menstrual function13-15.
Climacteric is defined as a group of physiological 
events manifested as a decline in ovarian function, both 
before and after the last menstrual period16. It is a uni-
versal phenomenon and includes other aspects, such as 
the end of a woman’s childbearing years and the so-called 
“empty-nest syndrome” when children leave home17. 
The manner in which each woman reacts to this period 
in her life varies greatly according to cultural/psychoso-
cial/biological factors and social relationships18. There 
is currently no consensus on the impact of menopausal 
status on quality of life. Some studies have demonstrated 
that menopause has a negative influence on quality of 
life scores19,20, whereas others have not shown this18. In 
addition, several studies have shown that menopausal 
transition-associated symptoms such as hot flashes and 
those caused by genital atrophy have a greater negative 
influence on quality of life than do cultural and psycho-
social factors21–23.
In the near future, an increasing number of women 
with liver transplants will experience menopausal transi-
tions. However, there are few studies evaluating meno-
pausal transitions in this particular female subgroup. We 
postulated that variations in serum concentrations of sex 
hormones and long-term use of immunosuppressive agents 
would result in worse quality of life and more intense 
climacteric symptoms in women with liver transplants 
than in those without them. We therefore conducted 
a study in women with and without a history of liver 
transplantation attending outpatient clinics of a uni-
versity hospital in southeastern Brazil. The aims of this 
study were to assess the influence of liver transplants and 
climacteric symptoms on quality of life in these subjects.
Methods
This cross-sectional study included women who 
had undergone liver transplantation and were at-
tending the Liver Transplant Outpatient Unit of the 
Clinics Hospital at the State University of Campinas 
(UNICAMP) School of Medicine and women with no 
history of liver disease undergoing follow-up at the 
Menopause Outpatient Clinic of the Professor Dr. 
José Aristodemo Pinotti Women’s Hospital (CAISM/
UNICAMP) from 4th February 2009 to 5th January 2011. 
All women aged 35 years or older who had received a 
liver transplant at least one year prior to the study were 
included. For each liver transplant recipient, a woman of 
similar age (within three years) and menstrual pattern 
was selected for comparison. Women were considered 
postmenopausal if they had been amenorrheic for at least 
12 months. Women who had menstrual irregularity 
without an identified anatomic cause were classified as 
perimenopausal. Women who had regular menstrual 
correlação apenas moderada (p<0,01; r=-0,5). CONCLUSÕES: As mulheres com transplante de fígado tiveram melhores escores de qualidade de vida 
no domínio relacionado ao meio ambiente e não tiveram sintomas climatéricos mais intensos. Os sintomas do climatério influenciaram negativamente a 
qualidade de vida nas transplantadas hepáticas, porém com menor intensidade do que nas mulheres sem antecedentes de doença hepática.
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cycles were considered premenopausal24. Women with 
debilitating clinical conditions that precluded them 
from participating in the study, those with a history 
of bilateral oophorectomy, and those who had taken 
hormones for treatment of menopausal symptoms or 
as contraception in the three months before the study 
were excluded. Thirty-three (33) women with liver 
transplants who met the inclusion criteria were identi-
fied. Of these, five could not be contacted by telephone 
and four declined to participate in the study. Therefore, 
the final number of participating transplant recipients 
was 24. The comparison group consisted of 28 women 
without a history of liver disease who were matched 
by age (within 3 years) and menstrual pattern with the 
transplant recipients. Therefore, the final number of 
women in the study was 52.
Interviews with the participants were conducted in the 
Menopause Outpatient Clinic of CAISM at UNICAMP. The 
same researcher interviewed all participants and obtained 
data on age, skin color, level of school education, marital 
status, date of transplantation, time since transplantation, 
disease causing liver failure, type of current immunosup-
pressive medication, presence of arterial hypertension 
or diabetes mellitus, smoking habits, date of menarche, 
date of last menstruation, menstrual pattern and if the 
woman was sexually active. Weight (kg), height (m) and 
arterial pressure (mmHg) were also measured. Women 
then responded to questionnaires that assessed menopausal 
symptoms and quality of life. All women signed free and 
informed written consents before their interviews. The 
study was approved by the Research Ethics Committee 
of UNICAMP under number 721/2008 and financed by 
FAPESP under number 2008/09726-6.
Menopause rating scale
Menopausal symptoms were assessed using a scale 
that has been formally validated according to the require-
ments for quality of life instruments and translated into 
Portuguese, namely the Menopause Rating Scale (MRS)25. 
This questionnaire consists of 11 questions covering 3 
dimensions of symptoms: psychological, somatic and uro-
genital. For each item, women could choose between five 
categories, namely no symptoms, less severe, moderate, 
severe and very severe symptoms. The total MRS score 
can vary from 0 (no symptoms) to 44 (maximum symp-
tomatology). MRS scoring can also be analyzed in relation 
to the 3 domains of psychological symptoms (depression, 
irritability, anxiety, physical and mental fatigue, accounting 
for 0–16 points); somatic (sweating/hot flashes, cardiac 
symptoms, sleep disturbances, and muscular and joint 
problems, accounting for 0–16 points); and urogenital 
symptoms (sexual issues, bladder disorders,; and vaginal 
dryness, accounting for 0–12 points)25.
Quality of life assessment
For assessment of quality of life, the abbreviated 
version of the World Health Organization (WHOQOL-
BREF) questionnaire was used. This questionnaire is a 
generic instrument used to assess quality of life that had 
already been validated and translated into Portuguese26. 
It contains 26 questions in four domains: physical, psy-
chological, social relationships, and environment. There 
are an additional two questions about quality of life and 
general health. Higher scores indicate a better quality 
of life. The questionnaire was administered directly to 
subjects by the researcher in face-to-face interviews26.
Statistical analysis
Sample characteristics were compared between the 
transplantation group and non-transplantation group by 
χ2 or Fisher’s exact tests. Neither the WHOQOL-BREF 
(physical, psychological and social) nor the MRS domains 
(psychological, somatic and urogenital) had normal 
distributions. Data transformation was used (quadratic, 
cubic and square root) to apply parametric tests. For the 
quality of life and health domains, data normalization was 
not possible. Comparisons were made between transplant 
recipients and non-transplant patients according to meno-
pausal status by Student’s t-test or the Mann-Whitney 
test. For each group studied, the quality of life domains 
(normal data) were assessed after eliminating the effect 
of control variables by analysis of variance. Correlations 
between WHOQOL-BREF domains and MRS domains 
were established by Pearson’s (normal data) or Spearman’s 
(non-normal data) correlation coefficients. A classification 
proposed by Santos in 2007 was used to classify linear 
correlations27. The level of significance was set at 5% 
and SAS version 9.2 was the software used for analysis.
Results
Relevant clinical and sociodemographic data on the 
women studied are shown in Table 1. Their mean age 
was 52.2±10.4 years (median 49.02, range 35.0–72.2). 
Mean patient age at liver transplantation was 46.0±12.3 
years (median 43.4, range 25.7–63.9). The mean time 
since transplantation was 6.1±3.3 years (median 5.8, 
range 1–12.5). The mean body mass index (BMI) was 
27.6±4.8 (median 26.7, range 18.8–40.9). Of the 52 
women studied, 14 (26.9%) were premenopausal, 13 
(25%) perimenopausal, and 25 (48.1%) postmenopausal. 
There were no significant differences between the groups 
of women regarding age, level of education, marital status, 
menopausal status, presence of diabetes mellitus, age at 
menarche, BMI, sexual activity, number of births (deliver-
ies), estradiol concentrations, and smoking habits. There 
was a significant difference in terms of skin color; 83.3% of 
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women in the liver transplant group were white, whereas 
only 53.6% were white in the comparison group (p=0.02). 
Fewer women with liver transplants had chronic arterial 
hypertension than in the comparison group (p=0.04). 
However, at the time of the interviews there were no 
significant differences between the groups in systolic or 
diastolic arterial blood pressures. As expected, there was a 
difference in the use of immunosuppressive drugs, because 
none of the women in the comparison group were taking 
this type of medication (p<0.01) (Table 1).
Domain scores for the WHOQOL-BREF are shown 
in Table 2. Comparing the group of women with liver 
transplants and those without a history of liver disease, 
statistically significant differences were observed in the 
domain related to environment, with values of 65.6 
(±12.7) for liver transplant recipients and 57.5 (±14.7) 
for women without a history of liver disease, both by 
bivariate analysis (p=0.03) and multivariate analysis 
adjusted for age, color, school education, marital status, 
sexual activity and comorbid conditions such as chronic 
arterial hypertension, diabetes mellitus and smoking 
(p=0.01) (Table 2).
A comparison between women according to history 
of liver transplantation can be seen in Table 3, which 
shows WHOQOL-BREF scores for premenopausal and 
peri/postmenopausal women. In the liver transplant 
group, no difference between peri/postmenopausal and 
premenopausal women in quality of life was observed. In 
the comparison group, there was a significant difference 
in the physical domain, with values of 80.1 (±9.6) for 
premenopausal and 64.1 (±19.3) for peri/postmenopausal 
women (p=0.04). Again, in the comparison group, for the 
question on general health, values of 85.7 (±13.4) for 
premenopausal and 60.7 (±29.1) for peri/postmenopausal 
women (p=0.04) were found (Table 3).
For statistical analysis of MRS scores, different 
approaches were used. First, total scores and domain 
scores from the questionnaires were compared according 
to history of liver transplantation. No significant dif-
ference was noted in any domain of the questionnaire. 
Second, MRS scores were compared in premenopausal 
women only; again, no significant difference was noted 
in any domain. Finally, peri/postmenopausal women 
alone were compared; again, no significant difference 
was observed (Table 4).
To assess the influence of menopausal symptoms 
on quality of life scores both in the liver transplant and 
comparison groups, correlation coefficients were applied 
between domain scores for the MRS and WHOQOL-
BREF. In the transplantation group, there were mod-
erately negative correlations (i.e. higher MRS scores 
corresponding to worse quality of life) between psycho-
logical symptoms on the MRS and the physical domain 
of the WHOQOL-BREF (p<0.01, r=-0.6), between 
somatic symptoms of the MRS and the physical (p<0.01, 
r= 0.5) and general health (p<0.01, r=-0.6) domains of 
the WHOQOL-BREF, and between the total MRS score 
and the physical (p<0.01, r=-0.6) and general health 
(p<0.01, r=-0.5) domains of the WHOQOL-BREF. There 
were weakly negative correlations between psychological 
Liver 
transplantation Control p-value
n (%) n (%)
Age 1.0
≤49 years 12 (50.0) 14 (50.0)
>49 years 12 (50.0) 14 (50.0)
Color 0.02
White 20 (83.3) 15 (53.6)
Non-white 4 (16.7) 13 (46.4)
Schooling 0.06*
0–7 years 8 (33.3) 16 (57.1)
8–12 years 13 (54.2) 12 (42.9)
>12 years 3 (12.5) 0 (0.0)
Relationship status 0.1
With partner 14 (58.3) 22 (78.6)
Without partner 10 (41.7) 6 (21.4)
Hypertension 0.04
Yes 4 (16.7) 12 (42.9)
Diabetes mellitus 0.2*
Yes 5 (20.8) 2 (7.1)
Menopausal status 0.4
Premenopausal 7 (29.2) 7 (25.0)
Perimenopausal 4 (16.7) 9 (32.1)
Menopausal 13 (54.2) 12 (42.9)
Menarche 0.6
≤13 years 13 (54.2) 17 (60.7)
>13 years 11 (45.8) 11 (39.3)
Sexually active 0.9
Yes 16 (66.7) 19 (67.9)
BMI 0.7
≤27 12 (50.0) 15 (53.6)
>27 12 (50.0) 13 (46.4)
Immunosuppression <0.01
No corticosteroids 16 (66.7) 28 (100.0)
With corticosteroids 8 (33.3) 0 (0.0)
Parity 0.2*
0 3 (12.5) 3 (10.7)
1 9 (37.5) 5 (17.9)
≥2 12 (50.0) 20 (71.4)
Serum estradiol concentration 0.7
<44.5 pg/mL 14 (58.3) 17 (63.0)
≥44.5 pg/mL 10 (41.7) 10 (37.0)
Smoking 0.3*
Yes 1 (4.2) 4 (14.3)
Unasterisked p-values, χ2 test; *Fisher´s exact test; BMI: Body Mass Index.
Table 1. Clinical and sociodemographic data according to liver transplantation status (n=52)
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Liver transplant recipients (n=24) Control (n=28)
Domain Mean SD Mean SD p-valuea p-valueb
Physical 66.2 15.0 68.1 18.6 0.6 0.44
Psychological 66.5 17.1 67.4 16.6 0.8 0.84
Social relationships 64.2 28.5 59.5 24.1 0.2 0.27
Environment 65.6 12.7 57.5 14.7 0.03 0.01
Overall QOL 79.2 17.6 72.3 14.2 0.1* **
General health 76.0 20.2 67.0 28.1 0.3* **
aStudent’s t-test. bAnalysis of variance with adjustment for age, race, education, marital status, sexual activity, comorbidities. *Mann-Whitney test. **Not assessed. QOL: quality of life.
Table 2. Scores for the World Health Organization quality of life questionnaire – abbreviated version (liver transplant recipients and con trols) (n=52)
Domain Premenopausal (n=7) Peri/postmenopausal (n=17)
p-value
(Liver transplantation) Mean SD Mean SD
Physical 72.5 13.9 63.7 15.1 0.1
Psychological 72.0 16.8 64.2 17.1 0.2
Social relationships 72.6 20.3 60.8 31.2 0.4
Environment 67.0 12.5 65.1 13.1 0.7
Overall QOL 89.3 13.4 75.0 17.7 0.08*
General health 85.7 19.7 72.1 19.5 0.1*
Domain Premenopausal (n=7) Peri/postmenopausal (n=21)
p-value
(Control) Mean SD Mean SD
Physical 80.1 9.6 64.1 19.3 0.04
Psychological 76.8 7.9 64.3 17.7 0.1
Social relationships 64.3 13.4 57.9 26.8 0.8
Environment 62.5 4.0 55.8 16.6 0.3
Overall QOL 75.0 0.0 71.4 16.4 0.6*
General health 85.7 13.4 60.7 29.1 0.04*
Table 3. Scores for the World Health Organization quality of life questionnaire – abbreviated version according to history of liver transplantation (premenopausal versus peri/postmenopausal) (n=52)
QOL: quality of life; WHOQOL-BREF: World Health Organization quality of life questionnaire – abbreviated version.
Unasterisked p-values, Student’s t-test; *Mann-Whitney test.
Total group
Liver transplantation (n=24) Control (n=28)
p-value
Mean SD Mean SD
Psychological 5.1 3.6 4.9 3.6 0.6
Somatic 3.5 2.8 4.2 3.5 0.8
Urogenital 2.0 1.9 2.0 2.2 0.9
Total score 10.7 6.0 11.1 7.8 0.8
Premenopausal
Liver transplantation (n=7) Control (n=7)
p-value
Mean SD Mean SD
Psychological 4.6 2.6 2.3 2.1 0.1
Somatic 1.9 1.6 1.3 1.3 0.4
Urogenital 1.9 2.0 0.3 0.8 0.07
Total score 8.3 4.7 3.9 3.0 0.06
Peri/postmenopausal
Liver transplantation (n=17) Control (n=21)
p-value
Mean SD Mean SD
Psychological 5.4 4.0 5.8 3.6 0.8
Somatic 4.2 2.9 5.2 3.5 0.5
Urogenital 2.1 1.9 2.5 2.3 0.7
Total score 11.7 6.4 13.5 7.4 0.4
p-values: Student’s t-test; SD: standard deviation.
Table 4. Scores for the Menopause Rating Scale (liver transplantation versus controls) (n=52)
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symptoms of the MRS and the psychological (p=0.04, 
r=-0.4) and environmental (p=0.01, r=-0.4) domains of 
the WHOQOL-BREF, and between the total MRS score 
and the psychological domain (p=0.03, r=-0.4) of the 
WHOQOL-BREF. In the comparison group, there was a 
strongly negative correlation between somatic symptoms 
on the MRS and the physical domain of the WHOQOL-
BREF (p<0.01; r=-0.8). There were moderately negative 
correlations between psychological symptoms of the 
MRS and the physical domain of the WHOQOL-BREF 
(p<0.01; r=-0.5), between somatic symptoms of the 
MRS and general health (p<0.01; r =-0.5) domain of 
the WHOQOL-BREF, and between the total MRS score 
and the physical (p<0.01, r=-0.7) and general health 
(p<0.01, r=-0.5) domains of the WHOQOL-BREF. There 
were weakly negative correlations between psychological 
symptoms of the MRS and the environmental (p=0.03, 
r=-0.4) and general health (p=0.01, r=-0.4) domains of 
the WHOQOL-BREF, between somatic symptoms of the 
MRS and the environmental domain (p=0.01, r=-0.4) of 
the WHOQOL-BREF, and between the total MRS score 
and psychological (p=0.01, r=-0.4) and environmental 
(p=0.01, r=-0.4) domains of the WHOQOL-BREF.
Discussion
The aim of this study was to obtain an accurate under-
standing of how liver transplantation influences quality of 
life and menopausal symptoms in women. Furthermore, 
we correlated menopausal symptoms with quality of life 
scores to measure the effect of these symptoms on quality 
of life in liver transplant recipients.
Women with a history of liver transplantation had 
better quality of life scores in the domain related to 
environment than did women with no history of liver 
disease, even after adjusting for the remaining variables 
such as age, color, school education, marital status, 
sexual activity, chronic arterial hypertension, diabetes 
mellitus and smoking. This result is in agreement with 
previously reported data. Telles-Correia et al. reported 
that one month after liver transplantation, patients with 
end-stage liver disease have significant improvements 
in quality of life in the physical and mental domains28. 
There is significant improvement in quality of life in 
the physical domain28 six months after transplantation, 
and after three to five years there is an even greater 
improvement in quality of life because by this stage 
transplant recipients have achieved greater psychoso-
cial stability9. In our study, it is noteworthy that liver 
transplant recipients not only had good quality of life 
but indeed superior values than did women with no 
history of liver transplantation. We believe that several 
factors may have contributed to this finding.
First, in this study the mean time since transplantation 
was approximately six years. As previously reported, the 
more time has elapsed since transplantation, the higher 
the quality of life scores are. Furthermore, women with a 
history of liver transplantation receive multidisciplinary 
follow-up care. It is likely that women feel strongly sup-
ported by this type of management and that it therefore has 
a beneficial effect on quality of life scores. Another factor 
that may explain this finding is that transplant recipients 
have already experienced periods of severely debilitated 
health. After going through the stressful experience of 
organ transplantation, recipients cherish their subsequent 
stability in health and tend to complain less about various 
aspects of their lives. Some authors suggest that surviving 
a potentially lethal disease may change internal values and 
moral concepts, altering the manner in which survivors 
cope with anxiety, depression and fatigue29-31.
Various studies have explored the influence of meno-
pausal status and climacteric symptoms on quality of 
life. Some authors have found no difference in overall 
quality of life between premenopausal and postmeno-
pausal women18,32-34, although some note that vasomotor 
symptoms have a negative effect on it18. In 2009, a study 
entitled “Study of Women’s Health across the Nation” 
found that, after final adjustment for all variables, the only 
independent relationship between menopausal status and 
quality of life indicators was with physical limitations. The 
same study showed that impaired quality of life during 
menopausal transition is most strongly related to symp-
toms such as vasomotor symptoms, urinary incontinence, 
sleep disturbances, and those caused by genital atrophy 
and morbid conditions associated with aging, such as 
rheumatoid arthritis, depression and stress23.
In 2012, a study entitled “Do Stage Transitions Result 
in Detectable Effects?” showed that the transition from 
premenopausal to postmenopausal status is associated 
with impaired quality of life, irrespective of the symptoms 
experienced17. In this study, negative impacts were more 
intense in the physical, pain and general health domains, 
as well as in energy levels and fatigue. One important 
finding of this study was that impaired quality of life did 
not impose limitations on daily living. It was suggested 
that, despite feeling worse, women did not let menopause 
interfere in their lives. Symptoms such as hot flashes and 
vaginal dryness in particular resulted in deterioration in 
quality of life, negatively interfering with social activities 
with friends and family17. In the present study, we analyzed 
the influence of menopausal status on quality of life scores 
in the liver transplant comparison groups separately. Being 
peri/postmenopausal did not influence quality of life in 
the liver transplant group. However, in the comparison 
group, peri/postmenopausal women had worse quality 
of life scores in the physical and general health domains.
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Liver transplant recipients did not have more intense 
climacteric symptoms than women in the comparison group. 
We found no significant differences between the groups in 
total or domain scores from either questionnaire, regard-
less of menopausal status. There is still no published data 
about menopausal symptoms in liver transplant recipients. 
Previous studies have reported only that the main gyneco-
logic symptom of premenopausal women with end-stage 
liver disease is secondary amenorrhea. After transplantation, 
most women resume having regular menstrual cycles13-15. 
Our results are in agreement with these data: we did not 
find more severe menopausal symptoms in liver transplant 
recipients than in comparison patients without liver dis-
ease. We therefore believe that when liver transplantation 
is successful, hormone metabolism reverts to normal and 
transplants have no influence on menopausal symptoms.
To test the hypothesis that menopausal symptoms 
have a greater influence on quality of life scores in liver 
transplant recipients than in comparison patients without 
liver disease, we measured correlation coefficients between 
various domains of the MRS and WHOQOL-BREF. 
We used both sets of coefficients to assess correlations 
between findings for women in the post transplanta-
tion and comparison groups and found that menopausal 
symptoms negatively influenced quality of life in both 
groups. Climacteric symptoms had greater influences on 
the physical and general health domains than they did 
on the environmental and psychological domains. For 
women in the comparison group, there was a strongly 
negative correlation between somatic symptoms in the 
MRS and the physical domain of the WHOQOL-BREF. 
In contrast, there was only a moderate association for 
women with liver transplants. We believe that the same 
explanation accounts for the higher quality of life scores 
and the smaller influence of somatic menopausal symp-
toms on quality of life in women with liver transplants.
A limitation of this study was the small number 
of cases and the fact that they were in two subgroups, 
which made it difficult to perform analyses and reach 
definitive conclusions. However, we did include all eli-
gible liver transplant patients attending our institution 
and available for study during the study period. Because 
this is the first study on quality of life and menopause 
symptoms in liver transplant recipients, we believe that, 
despite the limitation of few participants, our findings 
broaden knowledge about the needs of women undergoing 
liver transplantation, particularly during the climacteric 
years. Further studies are needed to enable the reaching 
of definitive conclusions.
Women with liver transplants had better quality of 
life scores in the environment domain and did not report 
more intense climacteric symptoms than did comparison 
patients without liver disease. Climacteric symptoms 
negatively influence quality of life in liver transplant 
recipients, although less intensely than in women without 
a history of liver disease.
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